Extracellular high-mobility group box 1 protein (HMGB1) as a mediator of persistent pain

• Published in: Molecular medicine (Cambridge, Mass.) Vol. 20; no. 1; pp. 569 - 578
• Main Authors: Agalave, Nilesh M, Svensson, Camilla I
• Format: Journal Article
• Language: English
• Published: England BioMed Central 2014; ScholarOne
• Subjects: Animals; Chronic Pain - metabolism; Cytokines; DNA methylation; HMGB1 Protein - metabolism; Humans; Kinases; Ligands; Mammals; Medicin och hälsovetenskap; Nervous system; Neurons; Pain; Pathogens; Phosphorylation; Proteins; Signal transduction; Tumor necrosis factor-TNF; Viral infections
• ISSN: 1076-1551; 1528-3658; 1528-3658
• DOI: 10.2119/molmed.2014.00176

Although originally described as a highly conserved nuclear protein, high-mobility group box 1 protein (HMGB1) has emerged as a danger-associated molecular pattern molecule protein (DAMP) and is a mediator of innate and specific immune responses. HMGB1 is passively or actively released in response to infection, injury and cellular stress, providing chemotactic and cytokine-like functions in the extracellular environment, where it interacts with receptors such as receptor for advanced glycation end products (RAGE) and several Toll-like receptors (TLRs). Although HMGB1 was first revealed as a key mediator of sepsis, it also contributes to a number of other conditions and disease processes. Chronic pain arises as a direct consequence of injury, inflammation or diseases affecting the somatosensory system and can be devastating for the affected patients. Emerging data indicate that HMGB1 is also involved in the pathology of persistent pain. Here, we give an overview of HMGB1 as a proinflammatory mediator, focusing particularly on the role of HMGB1 in the induction and maintenance of hypersensitivity in experimental models of pain and discuss the therapeutic potential of targeting HMGB1 in conditions of chronic pain.